Alphatec Holdings, Inc.

Report azionario NasdaqGS:ATEC

Capitalizzazione di mercato: US$1.3b

Alphatec Holdings Crescita futura

Criteri Future verificati 5/6

Alphatec Holdings prevede che gli utili e i ricavi cresceranno rispettivamente di 61.7% e 13% all'anno. Si prevede che l'EPS crescerà di 66.3% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 77.3% in 3 anni.

Informazioni chiave

61.7%

Tasso di crescita degli utili

66.31%

Tasso di crescita dell'EPS

Medical Equipment crescita degli utili16.1%
Tasso di crescita dei ricavi13.0%
Rendimento futuro del capitale proprio77.29%
Copertura analitica

Good

Ultimo aggiornamento12 May 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Seeking Alpha May 19

Alphatec - Slower Growth Seems Priced In Here

Summary Alphatec Holdings shares have dropped two-thirds YTD, now trading at just over 2x sales, reflecting sharply decelerating growth and persistent losses. Q1 2026 revenue grew only 14% to $192.1M, prompting a slight full-year sales guidance cut; adjusted EBITDA margins improved but remain heavily adjusted. Despite a $466M net debt load and ongoing dilution, Alphatec demonstrates real operating leverage, with manageable losses and a credible path toward profitability. Slowing topline growth and elusive margins temper enthusiasm, but current valuation appears compelling versus medtech peers, making Alphatec a speculative yet interesting play. Read the full article on Seeking Alpha
Aggiornamento della narrazione May 14

ATEC: 2026 Surgical Revenue Focus Will Support Future Upside Potential

Analysts have reduced their price target for Alphatec Holdings from about $24.62 to about $17.33 as they adjust assumptions for discount rate, revenue growth, profit margin, and future P/E in their models. What's in the News Alphatec Holdings issued earnings guidance for the fiscal year ending December 31, 2026, targeting total revenue of about $882 million, with surgical revenue expected to grow 17% as part of that outlook (corporate guidance).
Aggiornamento della narrazione Apr 29

ATEC: 2026 Revenue Guidance Will Drive Constructive Upside Case

Analysts have kept their $28.00 price target for Alphatec Holdings unchanged, noting that only modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E offset one another in their valuation work. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, indicating no change to its previously communicated outlook.
Aggiornamento della narrazione Apr 15

ATEC: 2026 Revenue Outlook Will Support Bullish Return Potential

Analysts have kept their $28.00 price target on Alphatec Holdings unchanged, citing updated assumptions that include a higher discount rate, stronger modeled revenue and profit margins, and a lower future P/E multiple that together balance out in their valuation work. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, maintaining its outlook for that period.
Aggiornamento della narrazione Mar 31

ATEC: 2026 Revenue Outlook And Biologics Partnership Will Support Upside

Analysts have trimmed their price target for Alphatec Holdings from $22.00 to $20.00, citing updated assumptions for revenue growth, profit margins and future P/E that together point to a more measured long term outlook for the shares. What's in the News Reaffirmed earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $890 million, described as about $126 million or 17% above full year 2025 revenue (Corporate Guidance).
Aggiornamento della narrazione Mar 17

ATEC: 2026 Revenue Outlook And Spine Biologics Partnership Will Support Upside

Analysts have left their $28.00 price target for Alphatec Holdings unchanged, citing a slightly higher assumed discount rate, a moderated revenue growth outlook, stronger projected profit margins, and a lower future P/E as key factors supporting the steady valuation. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $890 million.
Aggiornamento della narrazione Mar 03

ATEC: 2026 Revenue Outlook And Biologics Partnership Will Support Upside Potential

Analysts have adjusted their Alphatec Holdings target to $24.62, reflecting updated assumptions that combine slightly lower expected revenue growth with higher projected profit margins and a reduced future P/E multiple, while applying a somewhat higher discount rate. What's in the News Alphatec Holdings reaffirmed earnings guidance for the fiscal year ending December 31, 2026, with total revenue expected to approximate $890 million, described as about $126 million or 17% higher than full year 2025 revenue (company guidance).
Aggiornamento della narrazione Feb 17

ATEC: 2026 Revenue Guidance And Spine Biologics Deal Will Drive Upside

Analysts have maintained their $28.00 price target for Alphatec Holdings, citing steady model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions as reasons to hold their prior valuation line. What's in the News Alphatec Holdings issued revenue guidance for fiscal 2026, indicating expected total revenue of approximately $890m for the year ended December 31, 2026 (Corporate Guidance).
Aggiornamento della narrazione Feb 03

ATEC: Partnership And 2026 Revenue Outlook Will Reshape Spine Biologics Opportunity

Analysts have raised their fair value estimate for Alphatec Holdings from $23.00 to $28.00, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E that they believe better reflect the company’s current outlook. What's in the News Alphatec Holdings issued revenue guidance for fiscal 2026, indicating expected total revenue of about $890 million compared to full year 2025 (Corporate Guidance).
Aggiornamento della narrazione Jan 20

ATEC: Higher 2026 Revenue Outlook And New Partnership Will Support Upside

Analysts have lifted their price target on Alphatec Holdings from US$14.00 to US$22.00, citing updated assumptions around discount rate, revenue growth, profit margins and future P/E as the key drivers of the change. What's in the News Alphatec Holdings issued revenue guidance for fiscal 2026, indicating expected total revenue of approximately US$890 million for the year.
Articolo di analisi Jan 06

Are Alphatec Holdings, Inc. (NASDAQ:ATEC) Investors Paying Above The Intrinsic Value?

Key Insights Alphatec Holdings' estimated fair value is US$17.32 based on 2 Stage Free Cash Flow to Equity Alphatec...
Aggiornamento della narrazione Jan 06

ATEC: Higher 2025 Revenue Guidance Will Support A More Optimistic Outlook

Analysts have inched their price target for Alphatec Holdings higher to about $24.62 from $24.00, reflecting small tweaks to fair value estimates, discount rate assumptions, and a slightly higher future P/E multiple in their models. What's in the News Alphatec Holdings raised earnings guidance for the fiscal year ending December 31, 2025, indicating updated expectations for the business outlook.
Aggiornamento della narrazione Dec 14

ATEC: Revenue Will Reach 760 Million As Outlook Remains Favorable

Analysts have modestly raised their price target on Alphatec Holdings by 0.25 dollars to 24.00 dollars, reflecting slightly higher long term valuation multiples despite only marginal tweaks to growth, margin and discount rate assumptions. What's in the News Alphatec Holdings raised its earnings guidance for fiscal 2025, now expecting total revenue to increase 24 percent to 760 million dollars, compared with the prior outlook of 742 million dollars (company guidance filing) Valuation Changes Fair Value Estimate has risen slightly to 24.00 dollars from 23.75 dollars, reflecting a modest uplift in long term valuation.
Aggiornamento della narrazione Nov 29

ATEC: Revenue Will Reach $760 Million As Guidance Increases And Outlook Remains Steady

Analysts have maintained their fair value price target for Alphatec Holdings at $23.75, citing only minor adjustments to underlying financial assumptions along with a steady outlook for growth and profitability. What's in the News Alphatec Holdings raised its earnings guidance for the fiscal year ending December 31, 2025, reflecting increased confidence in the company's outlook (Key Developments).
Aggiornamento della narrazione Nov 15

ATEC: Total Revenue Will Reach $760 Million Next Year

Narrative Update on Alphatec Holdings: Analyst Price Target Revision Analysts have increased their price target for Alphatec Holdings from $20.54 to $23.75. This change reflects revised financial assumptions and updated expectations for the company’s future performance.
Aggiornamento della narrazione Nov 01

ATEC: Improved Margins And Revenue Projections Will Shape Future Performance

Analysts have raised their price target for Alphatec Holdings from $19.41 to $20.54 per share, citing improved profit margin forecasts and stronger projected revenue growth as key reasons for the increased valuation. What's in the News Alphatec Holdings, Inc.
Articolo di analisi Oct 05

Not Many Are Piling Into Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Yet

With a median price-to-sales (or "P/S") ratio of close to 2.8x in the Medical Equipment industry in the United States...
Aggiornamento della narrazione Sep 20

Expanding Spine Care And Integrated Tech Will Drive Future Opportunities

The slight increase in Alphatec Holdings’ future P/E ratio reflects higher growth expectations, which has contributed to a modest rise in its consensus analyst price target from $18.95 to $19.41. What's in the News Raised full-year 2025 revenue guidance to $742 million, up 21% year-over-year, surpassing previous forecast of $734 million.
Articolo di analisi Jul 28

Are Investors Undervaluing Alphatec Holdings, Inc. (NASDAQ:ATEC) By 43%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Alphatec Holdings fair value estimate is US$19.10 Current...
Articolo di analisi Jul 09

Should You Investigate Alphatec Holdings, Inc. (NASDAQ:ATEC) At US$11.60?

While Alphatec Holdings, Inc. ( NASDAQ:ATEC ) might not have the largest market cap around , it led the NASDAQGS...
User avatar
Nuova narrazione May 27

Robotics And Minimally Invasive Techniques Will Expand Spine Care

Innovative spine solutions and expanding minimally invasive offerings position Alphatec for sustained revenue growth and margin expansion amid rising global spine care demand.
Articolo di analisi May 11

Alphatec Holdings, Inc. (NASDAQ:ATEC) Stock Rockets 25% But Many Are Still Ignoring The Company

Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shares have had a really impressive month, gaining 25% after a shaky period...
Articolo di analisi Apr 20

Alphatec Holdings (NASDAQ:ATEC) Is Making Moderate Use Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Articolo di analisi Mar 01

Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates

Shareholders of Alphatec Holdings, Inc. ( NASDAQ:ATEC ) will be pleased this week, given that the stock price is up 18...
Articolo di analisi Jan 18

Alphatec Holdings, Inc. (NASDAQ:ATEC) Stock Rockets 31% But Many Are Still Ignoring The Company

Despite an already strong run, Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shares have been powering on, with a gain of 31...
Articolo di analisi Dec 19

Here's Why Alphatec Holdings (NASDAQ:ATEC) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Seeking Alpha Dec 03

Alphatec: A Big Recovery

Summary Alphatec, a medtech company focused on spine solutions, has faced investor concerns due to continued losses, cash burn, and increasing debt despite revenue growth. Shares plunged 40% after Q2 earnings, but have recovered following the release of the third quarter results following management's comments about positive cash flow in Q4. Management's optimistic outlook is further backed up by significant improvement in EBITDA seen in 2025. Despite the positive reaction, Alphatec still needs to prove its ability to reduce debt and avoid further dilution while executing its growth plans. Read the full article on Seeking Alpha
Articolo di analisi Nov 01

Alphatec Holdings, Inc. (NASDAQ:ATEC) Soars 50% But It's A Story Of Risk Vs Reward

Alphatec Holdings, Inc. ( NASDAQ:ATEC ) shareholders would be excited to see that the share price has had a great...
Articolo di analisi Aug 29

Positive Sentiment Still Eludes Alphatec Holdings, Inc. (NASDAQ:ATEC) Following 38% Share Price Slump

The Alphatec Holdings, Inc. ( NASDAQ:ATEC ) share price has fared very poorly over the last month, falling by a...
Articolo di analisi Aug 28

We Think Alphatec Holdings (NASDAQ:ATEC) Has A Fair Chunk Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Seeking Alpha Aug 05

Alphatec: Creating Some Real Back Pain For Its Shareholders

Summary Alphatec Holdings, Inc. experiences continued losses and dilution due to a focus on growth over margin improvements, causing concern for shareholders. Despite strong top-line growth and low sales multiples, the company's losses, cash burn, and increasing debt are worrying investors. Shares plummeted 40% after the company's second quarter results, amidst concerns about debt and limited options to finance the cash needs. Read the full article on Seeking Alpha

Previsioni di crescita degli utili e dei ricavi

NasdaqGS:ATEC - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20281,176551141558
12/31/20271,029-126911611
12/31/2026882-76206611
3/31/2026787-125-152N/A
12/31/2025764-143-445N/A
9/30/2025728-155-335N/A
6/30/2025682-166-3216N/A
3/31/2025642-166-82-11N/A
12/31/2024612-162-138-45N/A
9/30/2024573-178-198-80N/A
6/30/2024540-181-211-92N/A
3/31/2024512-192-202-99N/A
12/31/2023482-187-165-78N/A
9/30/2023450-172-135-62N/A
6/30/2023422-166-127-59N/A
3/31/2023389-152-130-69N/A
12/31/2022351-151-133-75N/A
9/30/2022319-157-145-82N/A
6/30/2022292-163-151-90N/A
3/31/2022270-164-146-80N/A
12/31/2021243-143-142-73N/A
9/30/2021213-131-125-65N/A
6/30/2021191-104-104-51N/A
3/31/2021159-81-84-48N/A
12/31/2020145-79-70-46N/A
9/30/2020133-69-64-49N/A
6/30/2020121-68-65-49N/A
3/31/2020119-65-57-42N/A
12/31/2019113-57N/A-33N/A
9/30/2019106-64N/A-33N/A
6/30/2019100-59N/A-32N/A
3/31/201995-53N/A-28N/A
12/31/201892-42N/A-26N/A
9/30/201893-12N/A-17N/A
6/30/201893-5N/A-11N/A
3/31/201895-1N/A-8N/A
12/31/2017102-5N/A-9N/A
9/30/2017103-21N/A-18N/A
6/30/2017106-28N/A-27N/A
3/31/2017114-27N/A-16N/A
12/31/2016120-26N/A-10N/A
9/30/2016128-23N/A4N/A
6/30/2016133-170N/A17N/A
3/31/2016120-171N/A13N/A
12/31/2015134-171N/A10N/A
9/30/2015153-165N/A6N/A
6/30/2015173-11N/A8N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Si prevede che ATEC diventerà redditizio nei prossimi 3 anni, il che è considerato una crescita più rapida del tasso di risparmio ( 3.5% ).

Guadagni vs Mercato: Si prevede che ATEC diventerà redditizia nei prossimi 3 anni, il che è considerato una crescita superiore alla media del mercato.

Guadagni ad alta crescita: Si prevede ATEC diventerà redditizia nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di ATEC ( 13% all'anno) crescerà più rapidamente del mercato US ( 11.7% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di ATEC ( 13% all'anno) crescerà più lentamente di 20% all'anno.


Previsioni di crescita dell'utile per azione


Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di ATEC sarà molto alto tra 3 anni ( 77.3 %).


Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/22 23:13
Prezzo dell'azione a fine giornata2026/05/22 00:00
Utili2026/03/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Alphatec Holdings, Inc. è coperta da 26 analisti. 11 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Matthew MiksicBarclays
Caitlin CroninCanaccord Genuity
Tao LevyDeutsche Bank